Patients who have obesity but don't have diabetes may now reap the benefits of using a GLP-1 receptor agonist.

Medtronic recently announced the launch of its new extended infusion set.

Can variability in HbA1c lead to a higher risk of mortality in persons with diabetes?

A Mendelian Randomization found a correlation between type 2 diabetes and heart failure, utilizing genetic markers.

Loss of healthy behaviors due to depression may increase the risk of the development of type 2 diabetes.

Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?

There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis. 

Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?

Evaluating the discordance between laboratory and continuous glucose monitoring estimated HbA1c.

A VERTIS CV sub study showed significant improvements in glycemic control after adding ertugliflozin to insulin-based regimens.